These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1292574)

  • 1. Treatment of the older hypertensive: paradigms, practices, and proofs.
    Amery A; Birkenhäger WH; Fagard R; Staessen J; Thijs L; de Leeuw PW
    Cardiovasc Drugs Ther; 1992 Dec; 6(6):565-9. PubMed ID: 1292574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is antihypertensive drug therapy needed in elderly patients with systolodiastolic hypertension?
    Thijs L; Fagard R; Lijnen P; Staessen J; Van Hoof R; Amery A
    J Hypertens Suppl; 1994 Sep; 12(6):S25-34. PubMed ID: 7799106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the major hypertension trials in the elderly.
    Staessen J; Fagard R; Lijnen P; Van Hoof R; Amery A
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1237-47. PubMed ID: 2009247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive drug treatment in elderly hypertensive subjects: evidence of protection.
    Staessen J; Fagard R; Van Hoof R; Amery A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S33-9. PubMed ID: 2469900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the main therapeutic trials conducted in hypertension.
    Amery A; Fagard R; Staessen J; Van Hoof R
    Acta Cardiol Suppl; 1988; 29():47-61. PubMed ID: 3291512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The older hypertensive. Assessment and treatment.
    Celis H; Fagard R; Staessen J; Thijs L; Amery A
    Neth J Med; 1993 Nov; 43 Suppl 1():S66-77. PubMed ID: 8289979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Hypertension in the Elderly and Frail Elderly.
    Ferri C; Ferri L; Desideri G
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):1-11. PubMed ID: 28181201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001.
    Primatesta P; Poulter NR
    J Hypertens; 2004 Jun; 22(6):1093-8. PubMed ID: 15167442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for hypertension in the elderly.
    Musini VM; Tejani AM; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000028. PubMed ID: 19821263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension.
    Wang JG; Staessen JA
    Drugs Aging; 2001; 18(5):345-53. PubMed ID: 11392443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent knowledge on the role of diastolic blood pressure in hypertensive patients on treatment].
    Leonetti G; Cuspidi C
    Recenti Prog Med; 2008 Apr; 99(4):191-9. PubMed ID: 18595632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.